Initial Views and Experiences of Vaping in Prisons: A Qualitative Study With People in Custody Preparing for the Imminent Implementation of Scotland's Prison Smokefree Policy.
Journal
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
ISSN: 1469-994X
Titre abrégé: Nicotine Tob Res
Pays: England
ID NLM: 9815751
Informations de publication
Date de publication:
16 02 2021
16 02 2021
Historique:
received:
25
11
2019
accepted:
21
05
2020
pubmed:
25
5
2020
medline:
4
5
2021
entrez:
25
5
2020
Statut:
ppublish
Résumé
Scotland is one of the few countries in which e-cigarettes were available in prisons before the introduction of a comprehensive national smokefree policy, to assist in its implementation. This qualitative study explores the initial views and experiences of vaping in this specific context, from the perspective of people in custody (prisoners). Twenty-eight people in custody were interviewed approximately 1-2 months after rechargeable e-cigarettes were made available in prisons and 2-5 weeks before implementation of a smokefree policy. Data were thematically analyzed to identify the range and diversity of views and experiences. Participants expressed support for e-cigarettes in preparation for the smokefree policy, describing their symbolic and practical value in this context. Uptake of vaping was strongly influenced by the need for participants to manage without tobacco in the near future. Participants evaluated their initial vaping experiences, either positively or negatively, in relation to the utility of e-cigarettes for mandated smoking abstinence and in providing satisfaction, pleasure, and novelty. Participant views on several issues related to e-cigarette use, both specific to the prison population (product choice and cost) and more generally (safety and long-term use), are explored. Our findings suggest possible benefits of e-cigarettes as one means of supporting smokefree policy in a population with many smokers. They also point to potential challenges posed by vaping in prisons and smokefree settings caring for similar populations. There is a need for ongoing measures to maximize the health benefits of smokefree settings and for further research on vaping in situations of enforced abstinence. To our knowledge, no published studies have explored views and experiences of vaping in prison, when rechargeable vapes were new and the removal of tobacco was imminent. The results can inform tobacco control policy choices, planning and implementation in prisons and similar settings. In prison systems that permitting vaping, it is important that other measures (eg, information campaigns and nicotine dependence services) are implemented concurrently to minimize potential risks to the health or personal finances of people in custody.
Identifiants
pubmed: 32447381
pii: 5843587
doi: 10.1093/ntr/ntaa088
pmc: PMC7885768
mid: EMS113364
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
543-549Subventions
Organisme : Chief Scientist Office
ID : SPHSU12
Pays : United Kingdom
Organisme : Cancer Research UK
ID : A27016
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12017/12
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S037519/1
Pays : United Kingdom
Organisme : Chief Scientist Office
ID : SPHSU-12
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 27016
Pays : United Kingdom
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco.
Références
BMC Public Health. 2019 May 24;19(1):635
pubmed: 31126265
Epidemiol Rev. 2018 Jun 1;40(1):82-95
pubmed: 29746635
Int J Environ Res Public Health. 2018 Jun 06;15(6):
pubmed: 29882828
Lancet. 2011 Mar 12;377(9769):956-65
pubmed: 21093904
Nicotine Tob Res. 2018 Jan 5;20(2):224-230
pubmed: 28199715
Nicotine Tob Res. 2019 Apr 17;21(5):602-616
pubmed: 29608714
Harm Reduct J. 2018 Jun 20;15(1):31
pubmed: 29921278
Drug Alcohol Rev. 2018 Nov;37(7):912-921
pubmed: 30051520
Tob Regul Sci. 2016 Apr;2(2):133-145
pubmed: 27042688
Am J Prev Med. 2018 Sep;55(3):345-352
pubmed: 30122215
Lancet. 2017 Apr 8;389(10077):1464-1474
pubmed: 28402828
Tob Control. 2014 Nov;23(e2):e87-8
pubmed: 24713614
Int J Drug Policy. 2017 Jun;44:84-85
pubmed: 28454011
Nicotine Tob Res. 2016 May;18(5):739-49
pubmed: 26315475
JAMA Psychiatry. 2015 Feb;72(2):103-4
pubmed: 25471086
Nicotine Tob Res. 2019 Jul 17;21(8):1027-1035
pubmed: 29767777
Respir Res. 2016 May 17;17(1):53
pubmed: 27184265
BMJ Open. 2019 Jun 25;9(6):e027799
pubmed: 31243033
N Engl J Med. 2019 Feb 14;380(7):629-637
pubmed: 30699054